Skip to Main Content

Paper Details

Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7.
Cardiovasc Drugs Ther
3
2022
ASCVD, AtheroscLerosis, Patients, Premature Atherosclerotic Cardiovascular Disease, antiplatelets, aspirin, clopidogrel, facility, patients, prasugrel, statin, statins, ticagrelor, ticlopidine
Author NameAffiliation
Dhruv MahttaMichael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations in Quality
Dhruv MahttaBaylor College of Medicine
Michelle T LeeMichael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations in Quality
Michelle T LeeBaylor College of Medicine
David J RamseyMichael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations in Quality
Julia M AkeroydMichael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations in Quality
Chayakrit KrittanawongBaylor College of Medicine
Christie M BallantyneBaylor College of Medicine
Christie M BallantyneBaylor College of Medicine
Christie M BallantyneBaylor College of Medicine
Christie M BallantyneBaylor College of Medicine
Laura A PetersenMichael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations in Quality
Salim S ViraniMichael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations in Quality
Salim S ViraniBaylor College of Medicine
Salim S ViraniBaylor College of Medicine
Salim S ViraniMichael E. DeBakey Veterans Affairs Medical Center
  • 1 - 16

Datasets

Release 1.2